Home LiteratureArticle Details
PMID: 19706705 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion.

Journal of virology ·Vol. 83 ·No. 21 ·2009-11-00 ·Pages 11152-65

Garcia T, Li J, Sureau C, Ito K, Qin Y, Wands J, Tong S

Abstract

Hepatitis B virus (HBV) contains three coterminal envelope proteins on the virion surface: large (L), middle (M), and small (S). The M and S proteins are also secreted as empty "subviral particles," which exceed virions by at least 1,000-fold. The S protein serves as the morphogenic factor for both types of particles, while the L protein is required only for virion formation. We found that cotransfecting replication constructs with a small dose of the expression construct for the missing L, M, and S proteins reconstituted efficient virion secretion but only 5 to 10% of subviral particles. The L protein inhibited secretion of subviral particles in a dose-dependent manner, whereas a too-high or too-low L/S protein ratio inhibited virion secretion. Consistent with the results of cotransfection experiments, a point mutation at the -3 position of the S gene AUG codon reduced HBsAg secretion by 60 to 70% but maintained efficient virion secretion. Surprisingly, ablating M protein expression reduced virion secretion but markedly increased the maturity of virion-associated genomes, which could be reversed by providing in trans both L and M proteins but not just M protein. M protein stability was dependent on the coexpression of S protein. Our findings suggest that efficient HBV virion secretion could be maintained despite drastic reduction in subviral particle production, which supports the recent demonstration of separate secretion pathways adopted by the two types of particles. The M protein appears to facilitate core particle envelopment, thus shortening the window of plus strand DNA elongation.

MeSH Terms
Animals Cell Line DNA, Viral Hepatitis B virus/genetics,metabolism,ultrastructure Humans Particle Size Promoter Regions, Genetic Secretory Pathway/physiology Viral Envelope Proteins/genetics,metabolism Viral Matrix Proteins/genetics,metabolism Virion/metabolism,ultrastructure
Chemicals
DNA, Viral L protein, hepatitis B virus Viral Envelope Proteins Viral Matrix Proteins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Garcia Tamako
Graduate Program in Pathobiology, Division of Biology and Medicine, Brown University, Providence, Rhode Island, USA.
Li Jisu
Sureau Camille
Ito Kiyoaki
Qin Yanli
Wands Jack
Tong Shuping
References (57)
57 references, click to expand
  1. The role of envelope proteins in hepatitis B virus assembly.
    Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):1059-63 PMID: 1992457
  2. Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment.
    J Cell Biol. 1992 Sep;118(6):1305-20 PMID: 1522109
  3. Hepatitis B virus replication.
    World J Gastroenterol. 2007 Jan 7;13(1):48-64 PMID: 17206754
  4. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity.
    J Virol. 1998 Jul;72(7):5573-8 PMID: 9621015
  5. pet, a small sequence distal to the pregenome cap site, is required for expression of the duck hepatitis B virus pregenome.
    J Virol. 1994 Mar;68(3):1564-72 PMID: 8107218
  6. Involvement of host cellular multivesicular body functions in hepatitis B virus budding.
    Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10205-10 PMID: 17551004
  7. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin.
    J Virol. 2007 Sep;81(17):9050-60 PMID: 17553870
  8. Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor.
    J Virol. 1993 Dec;67(12):7414-22 PMID: 8230462
  9. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide.
    Science. 1986 Dec 12;234(4782):1388-91 PMID: 3787251
  10. Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein.
    J Virol. 1987 Mar;61(3):782-6 PMID: 3806798
  11. Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.
    Cell. 1982 Jun;29(2):403-15 PMID: 6180831
  12. Characterization of a pre-S polypeptide on the surfaces of infectious avian hepadnavirus particles.
    J Virol. 1987 May;61(5):1384-90 PMID: 2437317
  13. Multiple functions of capsid protein phosphorylation in duck hepatitis B virus replication.
    J Virol. 1994 Jul;68(7):4341-8 PMID: 8207809
  14. Chimeric constructs between two hepatitis B virus genomes confirm transcriptional impact of core promoter mutations and reveal multiple effects of core gene mutations.
    Virology. 2009 May 10;387(2):364-72 PMID: 19327810
  15. Enhancement of hepatitis B virus infection by noninfectious subviral particles.
    J Virol. 1998 Feb;72(2):1462-8 PMID: 9445049
  16. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin.
    Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2235-9 PMID: 8134380
  17. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier.
    Virology. 1993 May;194(1):137-48 PMID: 8480417
  18. Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion.
    Virology. 2005 Feb 5;332(1):216-24 PMID: 15661154
  19. Assembly of viral particles in Xenopus oocytes: pre-surface-antigens regulate secretion of the hepatitis B viral surface envelope particle.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9338-42 PMID: 3467308
  20. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.
    Hepatology. 2003 Nov;38(5):1075-86 PMID: 14578844
  21. Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy.
    Virology. 1992 Jun;188(2):948-52 PMID: 1585662
  22. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.
    Cell. 1986 Nov 7;47(3):451-60 PMID: 3768961
  23. Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation.
    J Virol. 2007 Feb;81(4):1641-9 PMID: 17135319
  24. Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription.
    J Virol. 1984 Jul;51(1):181-91 PMID: 6328037
  25. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.
    J Virol. 2003 Jun;77(12):6601-12 PMID: 12767980
  26. Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation.
    J Biol Chem. 2006 Sep 29;281(39):29297-308 PMID: 16867982
  27. Hepatitis B virus biology.
    Microbiol Mol Biol Rev. 2000 Mar;64(1):51-68 PMID: 10704474
  28. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function.
    J Virol. 2004 Dec;78(23):13122-31 PMID: 15542664
  29. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.
    Virology. 1995 Nov 10;213(2):292-9 PMID: 7491754
  30. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.
    J Gen Virol. 2008 Nov;89(Pt 11):2882-2890 PMID: 18931087
  31. Detection and quantitation of hepatitis B surface antigen immune complexes (HBsAg-ICs) by an antigen-specific method. II. Circulating immune complexes (CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    J Immunol Methods. 1980;35(3-4):307-18 PMID: 6156971
  32. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice.
    J Virol. 1986 Dec;60(3):880-7 PMID: 3783819
  33. Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus.
    Clin Exp Immunol. 1991 Jun;84(3):493-500 PMID: 2044231
  34. Envelopment of the hepatitis B virus nucleocapsid.
    Virus Res. 2004 Dec;106(2):199-209 PMID: 15567498
  35. Central role of a serine phosphorylation site within duck hepatitis B virus core protein for capsid trafficking and genome release.
    J Biol Chem. 2003 Jul 25;278(30):28123-9 PMID: 12740387
  36. Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis.
    J Virol. 1996 Jul;70(7):4269-74 PMID: 8676448
  37. Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles.
    J Virol. 1998 Jan;72(1):778-82 PMID: 9420286
  38. Potent transcriptional interference by pausing of RNA polymerases over a downstream promoter.
    Mol Cell. 2009 Jun 12;34(5):545-55 PMID: 19524535
  39. Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression.
    J Virol. 2006 Jan;80(2):587-95 PMID: 16378961
  40. Hepatitis B virus large envelope protein interacts with gamma2-adaptin, a clathrin adaptor-related protein.
    J Virol. 2001 Jun;75(11):5343-51 PMID: 11333915
  41. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.
    Cell. 1986 Jan 31;44(2):283-92 PMID: 3943125
  42. Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking.
    J Virol. 2007 Apr;81(8):3842-51 PMID: 17267490
  43. Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1822-7 PMID: 9050863
  44. RNA-protein interactions in hepadnavirus reverse transcription.
    Front Biosci (Landmark Ed). 2009 Jan 01;14:1606-18 PMID: 19273150
  45. IgG subclass composition of antibodies to HBsAg in circulating immune complexes from patients with hepatitis B virus infections.
    Clin Exp Immunol. 1988 Apr;72(1):164-7 PMID: 3396217
  46. Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins.
    J Virol. 1987 Jul;61(7):2280-5 PMID: 3586133
  47. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host.
    J Virol. 1992 Sep;66(9):5682-4 PMID: 1501300
  48. Critical role of the 36-nucleotide insertion in hepatitis B virus genotype G in core protein expression, genome replication, and virion secretion.
    J Virol. 2007 Sep;81(17):9202-15 PMID: 17567705
  49. Properties of subviral particles of hepatitis B virus.
    J Virol. 2008 Aug;82(16):7812-7 PMID: 18524834
  50. Hepatitis B virus infection--natural history and clinical consequences.
    N Engl J Med. 2004 Mar 11;350(11):1118-29 PMID: 15014185
  51. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
    J Virol. 2006 Dec;80(24):11935-45 PMID: 17020942
  52. Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene.
    J Virol. 2004 Apr;78(7):3262-70 PMID: 15016847
  53. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles.
    J Virol. 1996 Jan;70(1):133-40 PMID: 8523517
  54. The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus.
    J Virol. 1994 Jun;68(6):4063-6 PMID: 8189544
  55. A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation.
    J Virol. 1997 Dec;71(12):9350-7 PMID: 9371594
  56. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
    Virology. 1995 Nov 10;213(2):660-5 PMID: 7491790
  57. Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.
    J Virol. 2009 Feb;83(4):1579-91 PMID: 19052077
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
1098-5514
Published
2009-11-00
Epub
2009-00-12
Pages
11152-65
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC2772768
Subset
IM
Grants
NCI NIH HHS · CA123544 · United States
NCI NIH HHS · R01 CA123544 · United States
NCI NIH HHS · F31 CA119941 · United States
NIAAA NIH HHS · AA08169 · United States
NIAAA NIH HHS · R01 AA008169 · United States
NCI NIH HHS · CA109733 · United States
NCI NIH HHS · F31CA119941 · United States
NCI NIH HHS · R01 CA109733 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com